The future of health:
Our experience in Cardiovascular health

Cardiovascular diseases (CVD) have been the leading cause of mortality in many countries for decades, and the trend is not going downwards: it is projected that in 2030, 31% of deaths worldwide will be attributed to CVD.

Main risk factors are lifestyle-driven, mostly smoking habits, rich and salty diets, and lack of physical activity; and studies have shown that most types of CVD could well be prevented with suitable lifestyle changes.

Here lies one of the biggest challenges for the future of cardiovascular diseases: beyond medication, how to engineer lasting lifestyle changes?

We’ve worked on several projects on the future of cardiovascular health:

Cardiovascular - Think Next
Cardiovascular - Think Next
Cardiovascular - Think Next

Explore our case studies

If you’re curious about our experience in Cardiovascular health, explore our case studies below & reach out to us for more information!


CV-related conditions we’ve worked on: heart failure (HFrEF and HFpEF), hypertension, hyperkalaemia

Digital strategy: the patient of the future

Anticipating patients’ expectations for digital health in 5 years to future-proof digital strategy

Digital Therapeutics Landscape and patient adoption

Building the case for change for Digital Therapeutics in a large pharmaceutical company

Patient-centered design for a digital companion

Identifying what patients need from a companion app to help manage their chronic condition

Unique patient insights from our patient trendscoping study

With more than 1,300 respondents living with a chronic pain condition, our Patient Trendscoping study is also a source of unique insights on patient expectations and behaviours.

At Think Next, we also have a soft spot for family caregivers, as their contributions and burdens are often widely underappreciated. Our study captures insights from nearly 700 respondents supporting a loved one living with chronic pain.

With sizable patient groups living with conditions such as hypertension, high cholesterol, coronary heart disease or heart failure, we can delve into the trends that resonate the most with each patient group.